DK1670769T3 - Benzimidazole derivatives, compositions containing them, their preparation and uses thereof - Google Patents
Benzimidazole derivatives, compositions containing them, their preparation and uses thereofInfo
- Publication number
- DK1670769T3 DK1670769T3 DK04768667T DK04768667T DK1670769T3 DK 1670769 T3 DK1670769 T3 DK 1670769T3 DK 04768667 T DK04768667 T DK 04768667T DK 04768667 T DK04768667 T DK 04768667T DK 1670769 T3 DK1670769 T3 DK 1670769T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- compositions containing
- benzimidazole derivatives
- benzimidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0302573A SE0302573D0 (en) | 2003-09-26 | 2003-09-26 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| PCT/GB2004/004124 WO2005030732A1 (en) | 2003-09-26 | 2004-09-24 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1670769T3 true DK1670769T3 (en) | 2009-08-10 |
Family
ID=29246982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04768667T DK1670769T3 (en) | 2003-09-26 | 2004-09-24 | Benzimidazole derivatives, compositions containing them, their preparation and uses thereof |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US8633235B2 (en) |
| EP (1) | EP1670769B1 (en) |
| JP (1) | JP4896721B2 (en) |
| KR (1) | KR101170184B1 (en) |
| CN (2) | CN1886379A (en) |
| AR (1) | AR045819A1 (en) |
| AT (1) | ATE430135T1 (en) |
| AU (1) | AU2004276062B2 (en) |
| BR (1) | BRPI0414780B8 (en) |
| CA (1) | CA2539738C (en) |
| CO (1) | CO5680443A2 (en) |
| CY (1) | CY1110332T1 (en) |
| DE (1) | DE602004020907D1 (en) |
| DK (1) | DK1670769T3 (en) |
| ES (1) | ES2324669T3 (en) |
| HK (1) | HK1089436A1 (en) |
| HR (1) | HRP20090388T1 (en) |
| IL (1) | IL174215A0 (en) |
| IS (1) | IS8422A (en) |
| MX (1) | MXPA06003197A (en) |
| MY (1) | MY140630A (en) |
| NO (1) | NO20061839L (en) |
| NZ (1) | NZ545736A (en) |
| PL (1) | PL1670769T3 (en) |
| PT (1) | PT1670769E (en) |
| RU (1) | RU2346938C2 (en) |
| SA (1) | SA04250310B1 (en) |
| SE (1) | SE0302573D0 (en) |
| SI (1) | SI1670769T1 (en) |
| TW (1) | TW200521117A (en) |
| UA (1) | UA86776C2 (en) |
| UY (1) | UY28536A1 (en) |
| WO (1) | WO2005030732A1 (en) |
| ZA (3) | ZA200602446B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4667867B2 (en) | 2002-08-02 | 2011-04-13 | メルク・シャープ・エンド・ドーム・コーポレイション | Substituted furo [2,3-b] pyridine derivatives |
| SE0302573D0 (en) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| JP2008514592A (en) * | 2004-09-24 | 2008-05-08 | アストラゼネカ・アクチエボラーグ | Benzimidazole derivatives, compositions containing them, their preparation and their use III |
| EP1797077B1 (en) * | 2004-09-24 | 2012-02-15 | AstraZeneca AB | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| ATE545644T1 (en) | 2004-09-24 | 2012-03-15 | Astrazeneca Ab | BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME, PRODUCTION THEREOF AND USES THEREOF I |
| CN101052639B (en) * | 2004-09-24 | 2010-10-27 | 阿斯利康(瑞典)有限公司 | Benzimidazole derivatives, composition containing thereof, its preparation method and application |
| JP2008518905A (en) | 2004-11-02 | 2008-06-05 | ファイザー株式会社 | Sulfonylbenzimidazole derivatives |
| CN101233098A (en) * | 2005-07-29 | 2008-07-30 | 阿斯利康(瑞典)有限公司 | Process for the preparation of geminal ((difluorocycloalkyl)methyl) amines |
| TW200745049A (en) | 2006-03-23 | 2007-12-16 | Astrazeneca Ab | New crystalline forms |
| TW200808769A (en) * | 2006-04-18 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
| US20080139846A1 (en) * | 2006-09-01 | 2008-06-12 | Astrazeneca Ab | New Process 298 |
| US8236841B2 (en) * | 2006-09-13 | 2012-08-07 | Kyowa Hakko Kirin Co., Ltd. | Fused heterocycle derivative |
| US20110086853A1 (en) * | 2009-10-08 | 2011-04-14 | William Brown | Therapeutic Compounds |
| RU2454234C1 (en) * | 2011-03-16 | 2012-06-27 | Константин Михайлович Аверин | 1,3-diethylbenzimidazolium salts as immunostimulating drugs and based pharmaceutical compositions |
| NZ702969A (en) * | 2012-06-13 | 2016-12-23 | Cytec Tech Corp | Stabilizer compositions containing substituted chroman compounds and methods of use |
| CA2877786C (en) | 2012-06-26 | 2020-08-25 | Bayer Pharma Aktiengesellschaft | N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| CA3093189A1 (en) | 2018-03-07 | 2019-09-12 | Bayer Aktiengesellschaft | Identification and use of erk5 inhibitors |
| US20220227729A1 (en) | 2019-05-21 | 2022-07-21 | Bayer Aktiengesellschaft | Identification and use of kras inhibitors |
| CN112010789A (en) * | 2019-05-31 | 2020-12-01 | 中国科学院上海药物研究所 | Vinyl sulfonamide or vinyl amide compounds, and preparation method and application thereof |
| WO2023166450A1 (en) * | 2022-03-04 | 2023-09-07 | 삼진제약주식회사 | Novel heterocyclic compound and pharmaceutical composition comprising same |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1604908A (en) | 1965-06-24 | 1971-05-15 | Substd benzimidazoles - with anthelmintic,fungicidal activity and some with antiviral and antibacterial activity | |
| FR5354M (en) | 1965-09-10 | 1967-09-11 | ||
| US5387600A (en) | 1992-07-30 | 1995-02-07 | Fuji Photo Film Co., Ltd. | Treating arteriosclerosis using benzimidazole compositions |
| DE4237597A1 (en) | 1992-11-06 | 1994-05-11 | Bayer Ag | Substituted benzimidazoles |
| DE4237617A1 (en) | 1992-11-06 | 1994-05-11 | Bayer Ag | Use of substituted benzimidazoles |
| DE4237557A1 (en) | 1992-11-06 | 1994-05-11 | Bayer Ag | Substituted benzimidazoles |
| IL124969A (en) | 1995-12-28 | 2002-09-12 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them |
| US6348032B1 (en) | 1998-11-23 | 2002-02-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with benzimidazole derivatives |
| WO2001012600A1 (en) | 1999-08-12 | 2001-02-22 | Cor Therapeutics, Inc. | INHIBITORS OF FACTOR Xa |
| US6720317B1 (en) | 1999-09-17 | 2004-04-13 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| BR0014078A (en) | 1999-09-17 | 2002-12-31 | Millennium Pharm Inc | Xa factor inhibitors |
| US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
| US7115645B2 (en) | 2000-01-14 | 2006-10-03 | Schering Aktiengesellschaft | 1,2 diarylbenzimidazoles and their pharmaceutical use |
| CN1301975C (en) * | 2000-01-14 | 2007-02-28 | 舍林股份公司 | 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| US7329679B2 (en) * | 2000-01-27 | 2008-02-12 | Schering Aktiengesellschaft | 1,2 Diarylbenzimidazoles and their pharmaceutical use |
| WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| WO2002000651A2 (en) | 2000-06-27 | 2002-01-03 | Bristol-Myers Squibb Pharma Company | Factor xa inhibitors |
| JP2004515496A (en) | 2000-12-07 | 2004-05-27 | アストラゼネカ・アクチエボラーグ | Benzimidazole therapeutic agent |
| SE0101387D0 (en) | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
| EP1403255A4 (en) | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | Rho KINASE INHIBITORS |
| AR043633A1 (en) | 2003-03-20 | 2005-08-03 | Schering Corp | CANABINOID RECEIVERS LINKS |
| SE0301701D0 (en) | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0301699D0 (en) | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| WO2005007625A2 (en) | 2003-07-14 | 2005-01-27 | The University Of Tennessee Research Foundation | Heterocyclic amides with anti-tuberculosis activity |
| WO2005021547A2 (en) | 2003-08-28 | 2005-03-10 | Pharmaxis Pty Ltd. | Heterocyclic cannabinoid cb2 receptor antagonists |
| SE0302572D0 (en) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0302573D0 (en) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0302570D0 (en) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0302571D0 (en) | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| WO2005113542A2 (en) | 2004-05-20 | 2005-12-01 | Elan Pharmaceuticals, Inc. | N-cyclic sulfonamido inhibitors of gamma secretase |
| WO2006009876A2 (en) | 2004-06-17 | 2006-01-26 | Cengent Therapeutics, Inc. | Trisubstituted nitrogen modulators of tyrosine phosphatases |
| KR101155288B1 (en) | 2004-07-30 | 2012-07-02 | 엑셀리시스, 인코포레이티드 | Pyrrole Derivatives as Pharmaceutical Agents |
| US20060052421A1 (en) | 2004-09-09 | 2006-03-09 | Eastman Kodak Company | Conjugation agent |
| JP2008514592A (en) | 2004-09-24 | 2008-05-08 | アストラゼネカ・アクチエボラーグ | Benzimidazole derivatives, compositions containing them, their preparation and their use III |
| WO2006033628A1 (en) | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| ATE545644T1 (en) * | 2004-09-24 | 2012-03-15 | Astrazeneca Ab | BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME, PRODUCTION THEREOF AND USES THEREOF I |
| EP1797077B1 (en) | 2004-09-24 | 2012-02-15 | AstraZeneca AB | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
| WO2006033633A1 (en) | 2004-09-24 | 2006-03-30 | Astrazeneca Ab | Compounds, compositions containing them, preparations thereof and uses thereof ii |
| JP2008514591A (en) | 2004-09-24 | 2008-05-08 | アストラゼネカ・アクチエボラーグ | Benzimidazole derivatives and their use as cannabinoid receptor ligands |
| JP2008514589A (en) | 2004-09-24 | 2008-05-08 | アストラゼネカ・アクチエボラーグ | Compounds, compositions containing them, their preparation and their use IIII |
| EP1794150A1 (en) | 2004-09-24 | 2007-06-13 | AstraZeneca AB | Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| JP2008518905A (en) | 2004-11-02 | 2008-06-05 | ファイザー株式会社 | Sulfonylbenzimidazole derivatives |
| WO2006078941A2 (en) | 2005-01-20 | 2006-07-27 | Sirtris Pharmaceuticals, Inc. | Novel sirtuin activating compounds and methods of use thereof |
| TW200745049A (en) | 2006-03-23 | 2007-12-16 | Astrazeneca Ab | New crystalline forms |
| TW200808769A (en) | 2006-04-18 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
| TW200808772A (en) | 2006-06-13 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
-
2003
- 2003-09-26 SE SE0302573A patent/SE0302573D0/en unknown
-
2004
- 2004-09-24 RU RU2006113371/04A patent/RU2346938C2/en active
- 2004-09-24 DK DK04768667T patent/DK1670769T3/en active
- 2004-09-24 AT AT04768667T patent/ATE430135T1/en active
- 2004-09-24 MY MYPI20043910A patent/MY140630A/en unknown
- 2004-09-24 US US10/573,054 patent/US8633235B2/en active Active
- 2004-09-24 KR KR1020067005825A patent/KR101170184B1/en active IP Right Grant
- 2004-09-24 BR BRPI0414780A patent/BRPI0414780B8/en active IP Right Grant
- 2004-09-24 WO PCT/GB2004/004124 patent/WO2005030732A1/en active Application Filing
- 2004-09-24 CN CNA2004800350086A patent/CN1886379A/en active Pending
- 2004-09-24 CN CN2010105277900A patent/CN102010373A/en active Pending
- 2004-09-24 PT PT04768667T patent/PT1670769E/en unknown
- 2004-09-24 NZ NZ545736A patent/NZ545736A/en unknown
- 2004-09-24 PL PL04768667T patent/PL1670769T3/en unknown
- 2004-09-24 SI SI200431166T patent/SI1670769T1/en unknown
- 2004-09-24 AR ARP040103467A patent/AR045819A1/en not_active Application Discontinuation
- 2004-09-24 UY UY28536A patent/UY28536A1/en unknown
- 2004-09-24 JP JP2006527490A patent/JP4896721B2/en active Active
- 2004-09-24 AU AU2004276062A patent/AU2004276062B2/en active Active
- 2004-09-24 CA CA2539738A patent/CA2539738C/en active Active
- 2004-09-24 DE DE602004020907T patent/DE602004020907D1/en active Active
- 2004-09-24 MX MXPA06003197A patent/MXPA06003197A/en active IP Right Grant
- 2004-09-24 TW TW093129150A patent/TW200521117A/en unknown
- 2004-09-24 UA UAA200602693A patent/UA86776C2/en unknown
- 2004-09-24 EP EP04768667A patent/EP1670769B1/en active Active
- 2004-09-24 ES ES04768667T patent/ES2324669T3/en active Active
- 2004-09-26 SA SA04250310A patent/SA04250310B1/en unknown
-
2006
- 2006-03-09 IL IL174215A patent/IL174215A0/en unknown
- 2006-03-22 CO CO06028452A patent/CO5680443A2/en not_active Application Discontinuation
- 2006-03-24 ZA ZA200602446A patent/ZA200602446B/en unknown
- 2006-04-21 IS IS8422A patent/IS8422A/en unknown
- 2006-04-26 NO NO20061839A patent/NO20061839L/en not_active Application Discontinuation
- 2006-09-01 HK HK06109758.7A patent/HK1089436A1/en not_active IP Right Cessation
-
2007
- 2007-03-13 ZA ZA200702131A patent/ZA200702131B/en unknown
- 2007-03-16 ZA ZA200702226A patent/ZA200702226B/en unknown
-
2009
- 2009-07-07 HR HR20090388T patent/HRP20090388T1/en unknown
- 2009-07-08 CY CY20091100725T patent/CY1110332T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS8422A (en) | Benzimidazole derivatives, preparations containing them, their preparation and their use | |
| IS8219A (en) | Benzimidazole derivatives, preparations containing them, their preparation and use | |
| NO20055018D0 (en) | Anti-amyolide antibodies, compositions, methods and applications | |
| DK1673349T3 (en) | Benzimidazole derivatives: preparation and pharmaceutical applications | |
| IS8220A (en) | Benzimidazole derivatives, mixtures containing them, their preparation and use | |
| IS7520A (en) | Pyrimidinone Compounds, Compositions and Methods | |
| DK1765327T3 (en) | Compounds, Compositions and Methods | |
| NO20055568D0 (en) | Substituted 1,4-diazepines and uses thereof | |
| NO20053974D0 (en) | Tienopyrimidine Compounds and Their Use. | |
| DK2046715T5 (en) | SUBSTITUTED 1,3-DIPHENYL PROPANDER DERIVATIVES, PREPARATIONS AND APPLICATIONS THEREOF | |
| IL175252A0 (en) | Benzimidazole derivatives and pharmaceutical compositions containing the same | |
| NO20054095D0 (en) | Pyridyloxymethyl and benzioxazolazabicyclic derivatives | |
| NO20054135D0 (en) | Kipolinone / benzoxazine derivatives and uses thereof | |
| NO20053809D0 (en) | Diarylmethylindenepiperidine derivatives, process for their preparation, and use thereof | |
| ATE417648T1 (en) | PIN COMPOSITIONS | |
| DK1560826T3 (en) | Pyridopyrimidinone Derivatives, Processes for their Preparation and Pharmaceutical Compositions Containing These | |
| HK1104823A1 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i | |
| DE502004002225D1 (en) | Self-emulsifying preparations | |
| DK1558612T3 (en) | Imidazopyridine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| DK1812120T3 (en) | Skin-protecting, alkalinity-controlling composition and its use | |
| DK1611115T3 (en) | BENZOTHIAZOLD DERIVATIVE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF | |
| EP1797077A4 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i | |
| NO20053805D0 (en) | Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof | |
| DK1778265T3 (en) | Guanylhydrazone compounds, compositions, methods and uses | |
| DK1651677T3 (en) | Heparin-derived oligosaccharide mixtures, their preparation and pharmaceutical compositions containing these mixtures |